IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Neochem Bio Solutions Ltd.
Issue Open Date 02-Dec-25  
Issue Closing Date 04-Dec-25  
Application Money 100  
Allotment Money  
Price Band 93 - 98  
Minimium Application No. 2400  
Issue Size (Shares) 3285600  
Market Lot 1.00  
Objective
1. Funding the long-term working capital requirements of the Company.2. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company.3. General Corporate Purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     14088000   NA  
Qualified Institutional Buyers     19142400   NA  
Retail Individual Investors     14376000   NA  
Business Description
We are a specialty performance chemical company with a legacy of over four decades, engaged in the businessof manufacturing specialty performance chemicals with a diverse portfolio of over 350 customized formulationsacross four primary product segments viz.,(i
more...
Promoter's Holding
Total Share Capital   11418750  
Offered to Public   3285600  
Promoter's Holding (Pre-Issue)   91.12  
Promoter's Holding (Post-Issue)   66.7  
Address
303
W1
Opp. Vikramnagar Colony
Off. Iscon- Ambli Road
Ambli Daskroi
Ahmedabad ,
Gujarat ,
380058
Phone: 079-35217792
Email: compliance@neochem.in
Website: www.neochem.in
Registrar
MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
NSE
Lead Manager
Vivro Financial Services Pvt Ltd
Promoters
Hemangini Swapnil Dathia
Swapnil Rameshbhai Makati
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.